HDL cholesterol: levels, low and very high results

These are common adult reporting guides, not treatment goals. Current NHS guidance, for example, uses above 1.0 mmol/L for men and above 1.2 mmol/L for women as broad healthy levels, while U.S. sources commonly use low cutoffs of 40 and 50 mg/dL. Laboratories and regions may flag results differently.^{See reference 4,See reference 5,See reference 8}

The category on your own report should be interpreted with the laboratory method, age, sex-related reference framework, pregnancy or hormone context, illness and medicines. The table is not designed for children, and one number cannot set a personal cardiovascular plan.^{See reference 1,See reference 4,See reference 5}

The mmol/L boundaries above are four-decimal conversions of the mg/dL values. Near a boundary, classify from the laboratory's original result and unit rather than allowing a rounded conversion to move the result into another row.^{See reference 8}

HDL particles take part in moving cholesterol from tissues toward the liver, among other biological roles. A routine HDL-C test reports how much cholesterol is carried in those particles at the time of the blood draw. It does not count HDL particles or test how well they function.^{See reference 2,See reference 7,See reference 13}

That distinction explains an apparent contradiction: people with higher HDL-C often have lower risk in observational studies, yet genetic evidence and trials of medicines that raise HDL-C have not shown that simply pushing the number upward reliably prevents events. HDL-C is useful risk context, not proof of protection or a causal treatment target.^{See reference 9,See reference 10,See reference 13}

For HDL cholesterol, divide mg/dL by 38.67 to obtain mmol/L. The practical forward factor is 0.02586. To convert mmol/L to mg/dL, multiply by 38.67. This is the cholesterol conversion factor; triglycerides use a different factor.^{See reference 8}

The tools round only the displayed answer. For example, 40 mg/dL is 1.0344 mmol/L, 50 mg/dL is 1.2930 mmol/L, 60 mg/dL is 1.5516 mmol/L and 80 mg/dL is 2.0688 mmol/L. Near a threshold, use the report's original value and unit.^{See reference 4,See reference 8}

Low HDL-C often appears as part of a broader metabolic pattern: higher triglycerides, insulin resistance or diabetes, lower physical activity, smoking, excess weight or an eating pattern high in refined carbohydrate or trans fat. Genetics, illness and medicines can also contribute. The result cannot identify the cause by itself.^{See reference 4,See reference 18}

The useful question is usually not “How do I force HDL above a line?” but “What does the whole risk pattern show?” LDL-C, non-HDL-C, ApoB when appropriate, triglycerides, blood pressure, glucose-related markers, tobacco exposure, family history and previous cardiovascular disease can change the priority.^{See reference 1,See reference 2,See reference 3}

Very high HDL-C is not guaranteed protection. MedlinePlus labels values above 80 mg/dL (about 2.07 mmol/L after conversion) elevated. Large observational studies and a 2024 meta-analysis report non-linear associations at very high concentrations, but the concentration linked with higher risk differs by sex and cohort, and some studies do not show the same pattern.^{See reference 4,See reference 8,See reference 11,See reference 12}

The evidence does not establish one universal dangerous HDL level or prove that HDL-C itself causes harm. Persistent unexpectedly high results can reflect genetics, excess alcohol, hyperthyroidism or other context. Review the full lipid pattern and possible cause instead of trying to lower HDL on your own.^{See reference 4,See reference 11,See reference 12}

LDL-C and non-HDL-C describe cholesterol carried in atherogenic particles, while ApoB estimates their number. Triglycerides help identify a common low-HDL metabolic pattern. Lp(a) adds a largely inherited risk layer that HDL cannot erase. These markers answer different questions and should not be collapsed into one “good versus bad” score.^{See reference 1,See reference 2,See reference 3,See reference 19}

The total-cholesterol-to-HDL ratio divides total cholesterol by HDL-C. The triglyceride-to-HDL ratio is also used in research and some reports. A ratio can summarize a pattern, but it can hide an important individual value and does not diagnose insulin resistance. Use the components, validated risk assessment and clinical context rather than treating one ratio as a verdict.^{See reference 1,See reference 2,See reference 3,See reference 19}

Niacin, fibrates and CETP inhibitors can raise HDL-C. In a meta-analysis of 39 randomized trials involving 117,411 participants, these HDL-targeted drug classes did not reduce all-cause mortality, coronary mortality, myocardial infarction or stroke among statin-treated participants. The result does not mean every use of these medicines is wrong; it means an HDL rise is not proof of benefit.^{See reference 9}

Current care focuses on the risk and condition that have outcome evidence—often lowering LDL-C or non-HDL-C, treating severe triglyceride elevation, managing diabetes or blood pressure, stopping tobacco and using medicines for their proven indication. Do not start niacin or a supplement, or stop a prescribed medicine, based on an HDL table.^{See reference 1,See reference 2,See reference 3,See reference 9}

Repeat timing usually follows the reason for the lipid panel rather than HDL alone: routine risk reassessment, a change in cardiovascular treatment, investigation of an unexpected pattern or follow-up of a secondary cause. Current AHA public guidance says many adults can be screened every five years from age 19, but individual risk and treatment can require a different schedule.^{See reference 1,See reference 2}

When comparing results, use the same unit and note fasting status, recent illness, pregnancy or hormone context, alcohol pattern and medicine changes. A small HDL movement is rarely the main decision; the full lipid profile and overall risk trend matter more.^{See reference 1,See reference 4,See reference 6,See reference 8}